Lanli: I think there's like a moment right now we're, like, the public is ready to hear about the stuff. Public markets are supportive of our industry. And so, like, it, it was like the mix up, it felt like the right time. We did a sometime tevevy five milion dollar pipe. The facts got one point seven five billion dollars in it. Like, this gives us like m o to scale, tos pluck the heck out of this place.
First Jason explains how to deliver great investor updates & the benefits of doing them well (1:36). Then, Ginkgo Bioworks CEO Jason Kelly joins to discuss the expanding capabilities of synthetic biology (24:48), how Ginkgo is currently helping customers make products more effectively (35:58), the ethics & risks of editing DNA (51:53) & more!